Cybin (NYSEAM:CYBN) just made a strategic move, announcing plans to shift its U.S. listing from NYSE American to the Nasdaq Global Market, a change that could reshape how investors view this clinical ...

Wondering if Astellas Pharma is still worth buying after its big run, or if the easy money has already been made? In this article, we walk through what the market is pricing in and where the gaps ...

The health system uses technology that works with physicians in the EHR to ensure charting is complete and precise. Capturing a more accurate case mix index led to a seven-figure reimbursement boost ...

Background In December 2022, California prohibited the sale of most flavoured tobacco products; however, limited data are ...

Data collected under the Death in Custody Reporting Act has some serious problems. Here’s how we fixed some of them.

Families, sheriffs and providers agree: jail is often the default response to addiction, even as withdrawal can become a ...